Skip to main content
OpenTrials
Completed

NCT Number: NCT07478120

Muscle and Fat Mass in Preoperative Computed Tomography and a Neuromuscular Blocking Agent Dose

Deep neuromuscular blockade has benefits in various surgical procedures and reduces postoperative pain. While neuromuscular blockade dosages are often based on the patient's actual body weight, body composition can vary significantly depending on age, gender, and individual exercise levels. Therefore, uniformly estimating neuromuscular blockade dosages based on actual body weight can result in under- or over-administered neuromuscular blocking agents. Calculating neuromuscular blockade dosage based on actual body weight can be inaccurate, but it remains due to the difficulty of accurately quantifying human muscle and fat mass. Recent advances in image analysis techniques utilizing artificial intelligence models have led to the development of methods for quantifying muscle and fat mass from computed tomography (CT). Theoretically, a higher neuromuscular blockade dosage should be required as the muscle mass increases. This study aims to analyze the relationship between neuromuscular blocking agent dosage, onset time, profound blockade time, and recovery time, and muscle mass and fat mass calculated from preoperative CT scans.

Completed

Looking for future studies?

Notify Me

Key information

Age range

19 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Seoul National University Bundang Hospital

Gyeonggi-do, Sungnamsi, 13620, South Korea

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • American Society of Anesthesiologists physical class (ASA class) 1-3
  • Patients scheduled for elective gynecologic surgery under general anesthesia
  • Patients undergoing abdominal computed tomography for routine preoperative preparation

Exclusion criteria

  • Pregnant women
  • Decreased renal function (GFR<60mL/min/1.73m2).
  • Patients taking drugs that affect deep neuromuscular blockade
  • Patients with a history of neuromuscular and muscle disorders

Treatment and study plan

Neuromuscular block

Other

Neuromuscular blockade monitoring

Primary outcomes

  1. muscle and fat mass

    Time frame: intraoperative period

    subject's muscle and fat mass from preoperative computed tomography images.

Sponsors and collaborators

Lead sponsor

Seoul National University Bundang Hospital

Other

Registry information

Official study title

Relationship Between Muscle and Fat Mass Using Deep-learning Approach in Preoperative Computed Tomography and a Neuromuscular Blocking Agent Dose Required for Maintaining Deep Neuromuscular Blockade in Patients Undergoing Gynecological Surgery

Important dates

Study start
2021
Primary completion
2021
Study completion
2026
First posted
Mar 17, 2026
Registry last updated
Mar 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.